Pharmaceutical Industry

Celluris AG 

Monthey · Since 2016

The core activity of Celluris is the development and research of personalized cancer treatments through CAR-T immunotherapy, specifically the modification of patient cells to recognize and combat tumors.

Centenara Labs AG 

Baar · Since 2019

The core activity of Centenara Labs AG is the development and investment in therapies that combat age-related diseases such as cancer, muscle weakness, vision loss, and cognitive impairments. The company focuses on researching and developing medications that address the so-called "Hallmarks of Aging" to improve the health and well-being of older people and extend their lifespan.

Cerbios-Pharma SA 

Barbengo · Since 1979

The core activity of Cerbios-Pharma SA is the development and manufacturing of pharmaceutical active ingredients (APIs), in particular highly potent active ingredients (HPAPIs), antibody-drug conjugates (ADCs) and biologics, as a Contract Development and Manufacturing Organization (CDMO).

CHEMO AG, Vienna, Lugano Branch 

Lugano · Since 2006

The core activity of Chemo is the development, manufacture and marketing of pharmaceutical products, including: Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs) for human and veterinary use, Over-the-counter (OTC) products, and Dietary supplements and medical devices. The company also offers Contract Manufacturing (CMO) services and has a global presence with 15 manufacturing sites and 200 scientists and researchers.

Chemo Project SA 

Lugano · Since 1984

The core activity of Insud Pharma is the development, manufacture and marketing of pharmaceutical products. The company operates in the healthcare sector and offers innovative solutions for healthcare. The core activities include research and development (15 research and development centers), production (20 industrial facilities) and distribution of medicines.

Cilag Holding AG 

Zug · Since 2001

Cilag GmbH International 

Zug · Since 1984

Cimeio Therapeutics AG 

Basel · Since 2024

Cimeio Therapeutics AG develops Shielded Cell & Immunotherapy Pairs™, combining paired immunotherapies with cell‑shielding gene editing to treat hematologic disorders. The platform edits cell surface receptors in hematopoietic stem cells to preserve function while preventing depletion by antibodies, ADCs, CAR‑T cells and T‑cell engagers.

CIS Biopharma AG 

Bubendorf · Since 2023

The core activity of CIS BIOPHARMA AG is the development and research of cancer therapies, with the goal of developing more effective treatment methods for cancer patients and improving their quality of life.

Clinuvel AG 

Baar · Since 2008

The core activity of CLINUVEL is the development, manufacture and marketing of pharmaceutical products, in particular the product SCENESSE, as well as the expansion of the business into the cosmetics sector and other services within an integrated business model.

CNBS Unlimited GmbH 

Zurich · Since 2021

CNBS Unlimited GmbH operates the Cannabis Sommelier online shop, selling CBD products as well as headshop and grow-shop equipment. The assortment includes CBD oils, flower, extracts, vaporizers and related accessories, and the company provides a B2B contact for wholesale.

Columed SA 

Geneva · Since 2010

Columed SA provides commercial and legal services in the pharmaceutical sector and is also active in pharmaceutical retail. It offers services to both manufacturers and retailers of pharmaceutical products.

Combioxin SA 

Epalinges · Since 2015

The core activity of Combioxin SA is the development of life-saving medications for severe infections, particularly for the treatment of severe bacterial pneumonias. The company focuses on the development of innovative therapeutics, such as CAL02, a first-in-class anti-toxin agent used to neutralize virulence factors that play a crucial role in the development of organ failure and fatal complications in severe infections.

CONARTIX GmbH 

Schlieren · Since 2006

The core activity of Conartix Health AG is the development, manufacture and marketing of nature-based health products and dietary supplements, particularly based on plant-based substances and prebiotics, with the aim of promoting human health and quality of life.

Copexis SA 

La Conversion · Since 2004

The core activity of Copexis S.A. is consulting and supporting pharmaceutical development, particularly in the following areas: * Early-stage pharmaceutical development (from development candidate to clinical phase II) * Late-stage pharmaceutical development (clinical phase III and marketing authorization in Europe and Switzerland) * Strategic consulting and support for the implementation of solutions in the areas of: + Pharmaceutical manufacturing + Toxicology + Clinical trials + Regulatory affairs * Regulatory services (CH/EU) * Corporate development and management Copexis positions itself as a strategic partner for companies in the pharmaceutical industry, offering comprehensive consulting and support for pharmaceutical development.

Corena Therapeutics Sàrl 

Marin-Epagnier · Since 2020

CoreQuest Sagl 

Lugano · Since 2008

CoreQuest Sagl is a pharmaceutical company conducting research and development of pharmaceutical products and medical devices in nephrology and surgical areas. It develops biocompatible hypertonic solutions for peritoneal dialysis, designs devices and monitoring techniques for dialysis patients, and pursues research programs addressing chronic renal failure and congestive heart failure, including a peritoneal ultrafiltration platform (Polycore).

CORETAG Diagnostics AG 

Basel · Since 2020

CORETAG Therapeutics AG 

Basel · Since 2020

The core activity of Coretag is the development of therapeutics for the treatment of cancer, particularly through the development of platforms for targeted tumor treatment. The company focuses on developing innovative solutions to improve treatment outcomes and the quality of life for cancer patients.

CORETAG Holding AG 

Basel · Since 2019